Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009
Published September 5, 2018 · Recall initiated: August 2, 2018
Summary
FDA records drug Class II recall D-1153-2018, published September 5, 2018 and initiated August 2, 2018. Recalling firm: Pharmcore Inc.; Status: Terminated; Reported quantity: 6 vials; Lot: Lot: IPA3-17 Exp. 07/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of assurance of sterility.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmcore Inc.
- Distributor
- Nationwide
- Lot
- Lot: IPA3-17 Exp. 07/2018
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHuman Chorionic Gonadotropin 6000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FLSeptember 5, 2018
- FDAHuman Chorionic Gonadotropin 20000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FLSeptember 5, 2018
- FDAMethylcobalamin 10 mg vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009September 5, 2018
- FDAHuman Chorionic Gonadotropin 5000 IU Vial Lyophilized 1109 East Hallandale Beach Blvd. Hallandale Beach, FLSeptember 5, 2018
- FDACoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520September 5, 2018
- FDADexpanthenol injectable, 250 mg/mL, 10 mL Single Dose vial, Rx only, Central Drugs Compounding Pharmacy, 520September 5, 2018
Questions about this recall
Was Ipamorelin 3 mg Lyophilized 1 vial 1109 East Hallandale Beach Blvd. Hallandale Beach, FL 33009 recalled?
Yes. FDA published recall D-1153-2018 on September 5, 2018. Reported hazard: Lack of assurance of sterility.
What should I do if I have this product?
Voluntary: Firm initiated · Letter